SONA NANOTECH INC.SONA NANOTECH INC.SONA NANOTECH INC.

SONA NANOTECH INC.

No trades
See on Supercharts

SONA fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Sona Nanotech, Inc. engages in the development of multiple proprietary methods for the manufacture of various types of gold nanoparticles in medical applications. It is involved in developing targeted hyperthermia, a photothermal cancer therapy, which uses therapeutic heat to treat solid cancer tumors. The company was founded by Gerrard Marangoni, Kulbir Singh, and Michael McAlduff on November 17, 2004 and is headquartered in Halifax, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

SONA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company